| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.809 | 0.003 | 0.809 | Alpha 1 adrenoreceptor antagonist | 0.369 0.008 CID_131770015 0.698 0.004 CID_46781917 0.262 0.014 CID_1355 | ||
| 0.807 | 0.003 | 0.807 | Alpha 1a adrenoreceptor antagonist | 0.359 0.007 CID_131770015 0.675 0.004 CID_46781917 0.236 0.013 CID_1355 | ||
| 0.802 | 0.004 | 0.802 | 5 Hydroxytryptamine antagonist | 0.315 0.017 CID_131770015 0.614 0.005 CID_46781917 0.361 0.014 CID_1355 | ||
| 0.799 | 0.003 | 0.799 | Alpha adrenoreceptor antagonist | 0.55 0.005 CID_131770015 0.689 0.004 CID_46781917 0.297 0.016 CID_1355 | ||
| 0.755 | 0.003 | 0.755 | 5 Hydroxytryptamine 1A agonist | 0.526 0.004 CID_131770015 0.622 0.004 CID_46781917 0.143 0.011 CID_1355 | ||
| 0.727 | 0.002 | 0.727 | Alpha 1 adrenoreceptor agonist | 0.301 0.004 CID_131770015 0.582 0.003 CID_46781917 0.208 0.006 CID_1355 | ||
| 0.709 | 0.004 | 0.709 | 5 Hydroxytryptamine 2 antagonist | 0.343 0.013 CID_131770015 0.592 0.005 CID_46781917 0.327 0.014 CID_1355 | ||
| 0.703 | 0.005 | 0.703 | Anticonvulsant | 0.175 0.103 CID_131770015 0.379 0.024 CID_46781917 0.28 0.046 CID_1355 | ||
| 0.678 | 0.004 | 0.73 | Dopamine antagonist | 0.233 0.016 CID_131770015 0.73 0.004 CID_46781917 0.209 0.018 CID_1355 | CID_46781917 | |
| 0.651 | 0.003 | 0.651 | 5 Hydroxytryptamine 2A antagonist | 0.282 0.012 CID_131770015 0.515 0.005 CID_46781917 0.277 0.013 CID_1355 | ||
| 0.641 | 0.005 | 0.659 | Antiadrenergic | 0.659 0.005 CID_131770015 0.541 0.005 CID_46781917 0.33 0.012 CID_1355 | CID_131770015 | |
| 0.64 | 0.005 | 0.658 | Adrenaline antagonist | 0.658 0.005 CID_131770015 0.54 0.005 CID_46781917 0.328 0.011 CID_1355 | CID_131770015 | |
| 0.599 | 0.004 | 0.639 | Dopamine D2 antagonist | 0.204 0.016 CID_131770015 0.639 0.004 CID_46781917 0.178 0.019 CID_1355 | CID_46781917 | |
| 0.588 | 0.004 | 0.588 | 5 Hydroxytryptamine 2C antagonist | 0.232 0.014 CID_131770015 0.418 0.005 CID_46781917 0.311 0.008 CID_1355 | ||
| 0.577 | 0.003 | 0.577 | Alpha 1b adrenoreceptor antagonist | 0.233 0.011 CID_131770015 0.463 0.004 CID_46781917 0.209 0.014 CID_1355 | ||
| 0.546 | 0.004 | 0.546 | 5 Hydroxytryptamine 1 agonist | 0.319 0.006 CID_131770015 0.419 0.005 CID_46781917 0.141 0.015 CID_1355 | ||
| 0.528 | 0.004 | 0.528 | Dopamine D4 antagonist | 0.126 0.02 CID_131770015 0.39 0.005 CID_46781917 0.233 0.01 CID_1355 | ||
| 0.527 | 0.004 | 0.527 | 5 Hydroxytryptamine 1A antagonist | 0.139 0.022 CID_131770015 0.374 0.006 CID_46781917 0.204 0.014 CID_1355 | ||
| 0.538 | 0.03 | 0.538 | Antiobesity | 0.382 0.073 CID_131770015 0.426 0.057 CID_46781917 0.487 0.04 CID_1355 | ||
| 0.508 | 0.004 | 0.508 | Alpha 2a adrenoreceptor antagonist | 0.299 0.007 CID_131770015 0.403 0.005 CID_46781917 0.246 0.009 CID_1355 | ||
| 0.493 | 0.003 | 0.493 | Alpha adrenoreceptor agonist | 0.31 0.005 CID_131770015 0.371 0.004 CID_46781917 0.248 0.006 CID_1355 | ||
| 0.492 | 0.004 | 0.492 | Histamine H1 receptor antagonist | 0.145 0.026 CID_131770015 0.308 0.006 CID_46781917 0.115 0.034 CID_1355 | ||
| 0.489 | 0.004 | 0.489 | Alpha 1d adrenoreceptor antagonist | 0.164 0.013 CID_131770015 0.373 0.004 CID_46781917 0.173 0.012 CID_1355 | ||
| 0.479 | 0.004 | 0.479 | Alpha 2 adrenoreceptor antagonist | 0.286 0.009 CID_131770015 0.353 0.006 CID_46781917 0.218 0.015 CID_1355 | ||
| 0.465 | 0.005 | 0.489 | 5 Hydroxytryptamine agonist | 0.195 0.015 CID_131770015 0.317 0.008 CID_46781917 0.489 0.005 CID_1355 | CID_1355 | |
| 0.466 | 0.014 | 0.466 | Psychostimulant | 0.381 0.026 CID_131770015 0.315 0.039 CID_46781917 0.435 0.018 CID_1355 | ||
| 0.456 | 0.005 | 0.456 | 5 Hydroxytryptamine 1 antagonist | 0.108 0.034 CID_131770015 0.291 0.01 CID_46781917 0.207 0.016 CID_1355 | ||
| 0.44 | 0.004 | 0.44 | Alpha 2b adrenoreceptor antagonist | 0.316 0.008 CID_131770015 0.331 0.007 CID_46781917 0.29 0.01 CID_1355 | ||
| 0.448 | 0.021 | 0.448 | HERG channel blocker | 0.166 0.114 CID_131770015 0.244 0.069 CID_46781917 0.345 0.039 CID_1355 | ||
| 0.417 | 0.008 | 0.417 | 5 Hydroxytryptamine 2B antagonist | 0.156 0.039 CID_131770015 0.334 0.012 CID_46781917 0.298 0.015 CID_1355 | ||
| 0.421 | 0.014 | 0.421 | Anesthetic general | 0.196 0.077 CID_131770015 0.363 0.022 CID_46781917 0.238 0.056 CID_1355 | ||
| 0.386 | 0.004 | 0.386 | Alpha 2c adrenoreceptor antagonist | 0.336 0.005 CID_131770015 0.305 0.006 CID_46781917 0.224 0.014 CID_1355 | ||
| 0.358 | 0.005 | 0.358 | Dopamine D3 antagonist | 0.144 0.016 CID_131770015 0.299 0.006 CID_46781917 0.147 0.015 CID_1355 | ||
| 0.378 | 0.031 | 0.378 | Potassium channel (Voltage-sensitive) blocker | 0.149 0.138 CID_131770015 0.195 0.099 CID_46781917 0.301 0.049 CID_1355 | ||
| 0.298 | 0.01 | 0.298 | Antihistaminic | 0.114 0.045 CID_46781917 0.108 0.049 CID_1355 | ||
| 0.294 | 0.01 | 0.294 | Histamine antagonist | 0.103 0.046 CID_46781917 0.099 0.048 CID_1355 | ||
| 0.269 | 0.005 | 0.269 | 5 Hydroxytryptamine 1B antagonist | 0.084 0.032 CID_131770015 0.134 0.015 CID_46781917 0.169 0.011 CID_1355 | ||
| 0.237 | 0.013 | 0.237 | Nav1.1 sodium channel blocker | 0.204 0.018 CID_131770015 0.218 0.016 CID_46781917 | ||
| 0.228 | 0.006 | 0.228 | Cannabinoid receptor antagonist | 0.068 0.051 CID_46781917 0.088 0.035 CID_1355 | ||
| 0.229 | 0.015 | 0.229 | Antibacterial (Helicobacter pylori) | 0.164 0.036 CID_46781917 0.141 0.055 CID_1355 | ||
| 0.221 | 0.01 | 0.324 | 5 Hydroxytryptamine 3A agonist | 0.119 0.057 CID_131770015 0.143 0.04 CID_46781917 0.324 0.003 CID_1355 | CID_1355 | |
| 0.213 | 0.005 | 0.213 | Cannabinoid CB1 receptor antagonist | 0.055 0.051 CID_131770015 0.063 0.042 CID_46781917 0.092 0.019 CID_1355 | ||
| 0.201 | 0.007 | 0.272 | Dopamine D4 agonist | 0.066 0.024 CID_131770015 0.102 0.014 CID_46781917 0.272 0.005 CID_1355 | CID_1355 | |
| 0.196 | 0.01 | 0.196 | Dopamine agonist | 0.099 0.028 CID_131770015 0.191 0.011 CID_46781917 0.143 0.016 CID_1355 | ||
| 0.19 | 0.011 | 0.315 | 5 Hydroxytryptamine 1F antagonist | 0.094 0.034 CID_131770015 0.116 0.025 CID_46781917 0.315 0.005 CID_1355 | CID_1355 | |
| 0.309 | 0.135 | 0.309 | Analgesic | 0.249 0.183 CID_46781917 0.279 0.159 CID_1355 | ||
| 0.186 | 0.014 | 0.384 | 5 Hydroxytryptamine 7 antagonist | 0.071 0.036 CID_131770015 0.107 0.024 CID_46781917 0.384 0.005 CID_1355 | CID_1355 | |
| 0.182 | 0.016 | 0.182 | Nav1.5 sodium channel blocker | 0.125 0.049 CID_46781917 0.119 0.055 CID_1355 | ||
| 0.288 | 0.124 | 0.583 | GABA C receptor rho-3 antagonist | 0.211 0.194 CID_46781917 0.583 0.009 CID_1355 | CID_1355 | |
| 0.159 | 0.006 | 0.161 | Dopamine D2 agonist | 0.078 0.015 CID_131770015 0.161 0.006 CID_46781917 0.06 0.021 CID_1355 | CID_46781917 | |
| 0.164 | 0.019 | 0.164 | Hedgehog signaling inhibitor | 0.103 0.059 CID_46781917 0.146 0.025 CID_1355 | ||
| 0.147 | 0.005 | 0.157 | 5 Hydroxytryptamine 3A antagonist | 0.07 0.042 CID_46781917 0.157 0.005 CID_1355 | CID_1355 | |
| 0.222 | 0.08 | 0.222 | Potassium channel blocker | 0.171 0.115 CID_1355 | ||
| 0.274 | 0.138 | 0.297 | Histamine release inhibitor | 0.254 0.152 CID_46781917 0.297 0.125 CID_1355 | CID_1355 | |
| 0.135 | 0.005 | 0.135 | Stearoyl-CoA desaturase inhibitor | 0.103 0.007 CID_46781917 | ||
| 0.159 | 0.032 | 0.159 | MAP kinase 13 inhibitor | 0.107 0.07 CID_46781917 | ||
| 0.238 | 0.118 | 0.329 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.212 0.144 CID_46781917 0.329 0.046 CID_1355 | CID_1355 | |
| 0.147 | 0.03 | 0.147 | Mediator release inhibitor | 0.134 0.037 CID_46781917 | ||
| 0.114 | 0.004 | 0.114 | Alpha 1L adrenoreceptor antagonist | 0.074 0.01 CID_131770015 0.101 0.004 CID_46781917 | ||
| 0.157 | 0.053 | 0.184 | Nav1.2 sodium channel blocker | 0.11 0.096 CID_131770015 0.184 0.04 CID_1355 | CID_1355 | |
| 0.12 | 0.023 | 0.17 | Bromodomain-containing protein 2 inhibitor | 0.17 0.005 CID_1355 | CID_1355 | |
| 0.098 | 0.004 | 0.098 | Vascular adhesion protein 1 inhibitor | 0.04 0.025 CID_46781917 0.076 0.005 CID_1355 | ||
| 0.228 | 0.137 | 0.228 | Ca(v)3.3 blocker | |||
| 0.103 | 0.017 | 0.238 | 5 Hydroxytryptamine 3 antagonist | 0.238 0.005 CID_1355 | CID_1355 | |
| 0.102 | 0.026 | 0.112 | Acetylcholine M4 receptor antagonist | 0.112 0.021 CID_1355 | CID_1355 | |
| 0.094 | 0.018 | 0.224 | 5 Hydroxytryptamine 3 agonist | 0.224 0.003 CID_1355 | CID_1355 | |
| 0.076 | 0.005 | 0.076 | Parathyroid hormone antagonist | 0.064 0.009 CID_131770015 0.068 0.008 CID_46781917 0.06 0.011 CID_1355 | ||
| 0.266 | 0.195 | 0.266 | Cyclophilin D inhibitor | 0.266 0.195 CID_46781917 | ||
| 0.089 | 0.018 | 0.089 | Sigma receptor antagonist | 0.05 0.034 CID_131770015 0.069 0.024 CID_46781917 | ||
| 0.09 | 0.019 | 0.228 | 5 Hydroxytryptamine 2A agonist | 0.072 0.035 CID_46781917 0.228 0.004 CID_1355 | CID_1355 | |
| 0.103 | 0.035 | 0.156 | Adrenaline agonist | 0.074 0.066 CID_131770015 0.156 0.013 CID_46781917 0.105 0.034 CID_1355 | CID_46781917 | |
| 0.093 | 0.027 | 0.197 | Dopamine D1 antagonist | 0.056 0.054 CID_131770015 0.197 0.011 CID_46781917 0.186 0.011 CID_1355 | CID_46781917 | |
| 0.078 | 0.014 | 0.09 | 5 Hydroxytryptamine 4 antagonist | 0.059 0.025 CID_46781917 0.09 0.009 CID_1355 | CID_1355 | |
| 0.066 | 0.007 | 0.075 | Nerve growth factor antagonist | 0.045 0.026 CID_46781917 0.075 0.004 CID_1355 | CID_1355 | |
| 0.167 | 0.108 | 0.167 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.147 0.132 CID_1355 | ||
| 0.105 | 0.047 | 0.105 | Hepatocyte growth factor antagonist | 0.099 0.052 CID_46781917 | ||
| 0.117 | 0.06 | 0.144 | GABA receptor agonist | 0.144 0.039 CID_1355 | CID_1355 | |
| 0.186 | 0.132 | 0.186 | Spasmolytic | 0.168 0.147 CID_46781917 0.181 0.136 CID_1355 | ||
| 0.063 | 0.01 | 0.097 | 5 Hydroxytryptamine 3B antagonist | 0.097 0.005 CID_1355 | CID_1355 | |
| 0.143 | 0.09 | 0.267 | Sigma receptor agonist | 0.123 0.111 CID_131770015 0.119 0.116 CID_46781917 0.267 0.045 CID_1355 | CID_1355 | |
| 0.065 | 0.012 | 0.09 | Dopamine D3 agonist | 0.045 0.022 CID_131770015 0.064 0.013 CID_46781917 0.09 0.008 CID_1355 | CID_1355 | |
| 0.101 | 0.054 | 0.171 | Lanosterol 14 alpha demethylase inhibitor | 0.171 0.007 CID_1355 | CID_1355 | |
| 0.079 | 0.032 | 0.079 | Adenosine A2a receptor antagonist | 0.073 0.035 CID_46781917 | ||
| 0.168 | 0.125 | 0.251 | Cyclic AMP phosphodiesterase inhibitor | 0.251 0.063 CID_1355 | CID_1355 | |
| 0.068 | 0.03 | 0.153 | Heat shock protein 90 beta antagonist | 0.153 0.005 CID_46781917 0.091 0.014 CID_1355 | CID_46781917 | |
| 0.057 | 0.02 | 0.057 | Antidiuretic hormone antagonist | |||
| 0.256 | 0.22 | 0.48 | 5 Hydroxytryptamine release inhibitor | 0.48 0.039 CID_1355 | CID_1355 | |
| 0.05 | 0.015 | 0.05 | Vasopressin 1 antagonist | |||
| 0.092 | 0.057 | 0.097 | Polo-like kinase-1 inhibitor | 0.083 0.076 CID_46781917 0.097 0.049 CID_1355 | CID_1355 | |
| 0.072 | 0.039 | 0.072 | Adenosine A2 receptor antagonist | 0.058 0.05 CID_46781917 | ||
| 0.162 | 0.129 | 0.561 | Aldehyde oxidase inhibitor | 0.168 0.124 CID_46781917 0.561 0.024 CID_1355 | CID_1355 | |
| 0.045 | 0.016 | 0.045 | Vasopressin 2 antagonist | |||
| 0.042 | 0.015 | 0.042 | Vasopressin 1A antagonist | |||
| 0.073 | 0.046 | 0.117 | Benzodiazepine agonist | 0.117 0.017 CID_1355 | CID_1355 | |
| 0.108 | 0.08 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.126 0.047 CID_1355 | CID_1355 | |
| 0.035 | 0.009 | 0.035 | Vasopressin 1A agonist | 0.032 0.012 CID_131770015 0.032 0.013 CID_46781917 | ||
| 0.094 | 0.071 | 0.111 | Insulin receptor antagonist | 0.111 0.05 CID_1355 | CID_1355 | |
| 0.273 | 0.252 | 0.477 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.477 0.045 CID_1355 | CID_1355 | |
| 0.09 | 0.07 | 0.14 | Phosphodiesterase 7B inhibitor | 0.14 0.025 CID_1355 | CID_1355 | |
| 0.201 | 0.184 | 0.201 | Beta lactamase inhibitor | |||
| 0.06 | 0.046 | 0.278 | 5 Hydroxytryptamine uptake inhibitor | 0.278 0.007 CID_1355 | CID_1355 | |
| 0.108 | 0.096 | 0.108 | Phosphodiesterase inhibitor | |||
| 0.068 | 0.057 | 0.156 | Phospholipase D inhibitor | 0.156 0.003 CID_1355 | CID_1355 | |
| 0.028 | 0.018 | 0.028 | Antidiuretic hormone agonist | |||
| 0.115 | 0.107 | 0.122 | Cell wall synthesis inhibitor | 0.122 0.096 CID_46781917 0.117 0.103 CID_1355 | CID_46781917 | |
| 0.066 | 0.058 | 0.066 | Lipase inhibitor | |||
| 0.017 | 0.012 | 0.017 | Vasopressin 2 agonist | |||
| 0.105 | 0.104 | 0.139 | Sodium channel (voltage-gated) blocker | 0.139 0.063 CID_1355 | CID_1355 | |
| 0.039 | 0.038 | 0.039 | Phosphodiesterase 10A inhibitor | |||
| 0.039 | 0.038 | 0.039 | Phosphodiesterase X inhibitor | |||
| 0.251 | 0.252 | 0.436 | Caspase 9 stimulant | 0.436 0.091 CID_1355 | CID_1355 | |
| 0.056 | 0.057 | 0.124 | Corticotropin releasing factor 2 receptor antagonist | 0.124 0.004 CID_1355 | CID_1355 | |
| 0.035 | 0.037 | 0.062 | Dopamine D5 antagonist | 0.062 0.018 CID_46781917 0.053 0.023 CID_1355 | CID_46781917 | |
| 0.029 | 0.032 | 0.031 | Protein kinase C beta II inhibitor | 0.031 0.025 CID_1355 | CID_1355 | |
| 0.056 | 0.06 | 0.059 | Phosphodiesterase 1C inhibitor | 0.059 0.05 CID_1355 | CID_1355 | |
| 0.12 | 0.125 | 0.15 | Polo-like kinase-3 inhibitor | 0.15 0.084 CID_1355 | CID_1355 | |
| 0.042 | 0.047 | 0.063 | Bromodomain-containing protein 3 inhibitor | 0.063 0.017 CID_1355 | CID_1355 | |
| 0.029 | 0.037 | 0.057 | p53 inhibitor | 0.057 0.01 CID_1355 | CID_1355 | |
| 0.046 | 0.056 | 0.173 | 5 Hydroxytryptamine 6 antagonist | 0.173 0.005 CID_1355 | CID_1355 | |
| 0.045 | 0.057 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 CID_1355 | CID_1355 | |
| 0.047 | 0.063 | 0.1 | Calcium channel T-type blocker | 0.1 0.016 CID_1355 | CID_1355 | |
| 0.115 | 0.135 | 0.185 | Neuropeptide Y1 antagonist | 0.185 0.026 CID_1355 | CID_1355 | |
| 0.051 | 0.072 | 0.06 | Phosphodiesterase 1A inhibitor | 0.06 0.04 CID_1355 | CID_1355 | |
| 0.037 | 0.059 | 0.05 | Heme oxygenase inhibitor | 0.05 0.013 CID_1355 | CID_1355 | |
| 0.045 | 0.069 | 0.166 | Adrenaline uptake inhibitor | 0.166 0.008 CID_1355 | CID_1355 | |
| 0.019 | 0.045 | 0.023 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 CID_1355 | CID_1355 | |
| 0.035 | 0.063 | 0.07 | Melanin-concentrating hormone receptor 1 antagonist | 0.07 0.024 CID_1355 | CID_1355 | |
| 0.033 | 0.065 | 0.055 | Glutamate (mGluR5) agonist | 0.055 0.021 CID_1355 | CID_1355 | |
| 0.034 | 0.066 | 0.071 | CC chemokine 4 receptor antagonist | 0.071 0.009 CID_1355 | CID_1355 | |
| 0.037 | 0.073 | 0.059 | Nicotinic alpha7 receptor agonist | 0.059 0.032 CID_1355 | CID_1355 | |
| 0.041 | 0.081 | 0.056 | MAP kinase kinase 9 inhibitor | 0.056 0.038 CID_1355 | CID_1355 | |
| 0.033 | 0.073 | 0.235 | 5 Hydroxytryptamine 2 agonist | 0.235 0.004 CID_1355 | CID_1355 | |
| 0.056 | 0.097 | 0.168 | Acetylcholine nicotinic agonist | 0.168 0.012 CID_1355 | CID_1355 | |
| 0.034 | 0.078 | 0.13 | Dopamine uptake inhibitor | 0.13 0.013 CID_1355 | CID_1355 | |
| 0.188 | 0.233 | 0.461 | Calcium channel activator | 0.461 0.009 CID_1355 | CID_1355 | |
| 0.016 | 0.062 | 0.108 | Potassium channel small-conductance Ca-activated activator | 0.108 0.004 CID_1355 | CID_1355 | |
| 0.059 | 0.106 | 0.099 | Insulin like growth factor 1 antagonist | 0.099 0.042 CID_1355 | CID_1355 | |
| 0.033 | 0.08 | 0.11 | Nicotinic neuronal receptor agonist | 0.11 0.01 CID_1355 | CID_1355 | |
| 0.047 | 0.096 | 0.072 | Amidase inhibitor | 0.072 0.045 CID_1355 | CID_1355 | |
| 0.087 | 0.136 | 0.114 | Sodium channel blocker | 0.114 0.092 CID_1355 | CID_1355 | |
| 0.025 | 0.075 | 0.053 | Glutamate (mGluR group I) agonist | 0.053 0.028 CID_1355 | CID_1355 | |
| 0.153 | 0.204 | 0.3 | 5 Hydroxytryptamine 3E antagonist | 0.3 0.005 CID_1355 | CID_1355 | |
| 0.087 | 0.139 | 0.259 | Toll-Like receptor 9 antagonist | 0.259 0.019 CID_1355 | CID_1355 | |
| 0.058 | 0.11 | 0.106 | Insulin growth factor antagonist | 0.106 0.043 CID_1355 | CID_1355 | |
| 0.06 | 0.115 | 0.076 | GABA A receptor agonist | 0.076 0.07 CID_1355 | CID_1355 | |
| 0.077 | 0.132 | 0.124 | Acetylcholine antagonist | 0.124 0.067 CID_1355 | CID_1355 | |
| 0.068 | 0.125 | 0.085 | Transforming growth factor beta 3 antagonist | 0.085 0.049 CID_1355 | CID_1355 | |
| 0.01 | 0.068 | 0.03 | CC chemokine 1 receptor antagonist | 0.03 0.013 CID_1355 | CID_1355 | |
| 0.077 | 0.135 | 0.127 | Cholinergic antagonist | 0.127 0.068 CID_1355 | CID_1355 | |
| 0.09 | 0.149 | 0.207 | Cytidine deaminase inhibitor | 0.207 0.044 CID_1355 | CID_1355 | |
| 0.035 | 0.095 | 0.136 | 5 Hydroxytryptamine 1D antagonist | 0.136 0.014 CID_1355 | CID_1355 | |
| 0.079 | 0.139 | 0.152 | Activin receptor-like kinase 4 inhibitor | 0.152 0.028 CID_1355 | CID_1355 | |
| 0.008 | 0.069 | 0.032 | Dopamine autoreceptor agonist | 0.032 0.012 CID_1355 | CID_1355 | |
| 0.141 | 0.203 | 0.488 | Superoxide dismutase inhibitor | 0.488 0.014 CID_1355 | CID_1355 | |
| 0.061 | 0.123 | 0.099 | Caspase 7 inhibitor | 0.099 0.029 CID_1355 | CID_1355 | |
| 0.055 | 0.118 | 0.152 | Acetylcholine agonist | 0.152 0.025 CID_1355 | CID_1355 | |
| 0.035 | 0.098 | 0.085 | Acetylcholine M5 receptor antagonist | 0.085 0.022 CID_1355 | CID_1355 | |
| 0.037 | 0.1 | 0.107 | Cyclin-dependent kinase 4 inhibitor | 0.107 0.024 CID_1355 | CID_1355 | |
| 0.03 | 0.095 | 0.076 | GABA A receptor antagonist | 0.076 0.023 CID_1355 | CID_1355 | |
| 0.038 | 0.105 | 0.153 | 5 Hydroxytryptamine 7 agonist | 0.153 0.004 CID_1355 | CID_1355 | |
| 0.08 | 0.147 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 CID_1355 | CID_1355 | |
| 0.043 | 0.111 | 0.109 | Bcl2 antagonist | 0.109 0.014 CID_1355 | CID_1355 | |
| 0.039 | 0.109 | 0.087 | Check point kinase 1 inhibitor | 0.087 0.034 CID_1355 | CID_1355 | |
| 0.054 | 0.125 | 0.115 | MDM2 inhibitor | 0.115 0.004 CID_1355 | CID_1355 | |
| 0.058 | 0.132 | 0.122 | Pim-3 kinase inhibitor | 0.122 0.03 CID_1355 | CID_1355 | |
| 0.018 | 0.092 | 0.032 | CDK6/cyclin D3 inhibitor | 0.032 0.028 CID_1355 | CID_1355 | |
| 0.042 | 0.116 | 0.083 | CXC chemokine receptor antagonist | 0.083 0.034 CID_1355 | CID_1355 | |
| 0.136 | 0.211 | 0.346 | 5 Hydroxytryptamine 1E antagonist | 0.346 0.011 CID_1355 | CID_1355 | |
| 0.028 | 0.104 | 0.076 | GABA receptor antagonist | 0.076 0.023 CID_1355 | CID_1355 | |
| 0.036 | 0.112 | 0.123 | Neuronal nicotinic receptor antagonist | 0.123 0.017 CID_1355 | CID_1355 | |
| 0.034 | 0.11 | 0.101 | Cyclin D1 inhibitor | 0.101 0.008 CID_1355 | CID_1355 | |
| 0.039 | 0.118 | 0.092 | Protein kinase C beta inhibitor | 0.092 0.018 CID_1355 | CID_1355 | |
| 0.066 | 0.144 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.044 CID_1355 | CID_1355 | |
| 0.04 | 0.119 | 0.129 | 5 Hydroxytryptamine 5A antagonist | 0.129 0.01 CID_1355 | CID_1355 | |
| 0.016 | 0.096 | 0.029 | Thymidine phosphorylase inhibitor | 0.029 0.013 CID_1355 | CID_1355 | |
| 0.135 | 0.215 | 0.307 | MAP-kinase-activated kinase 5 inhibitor | 0.307 0.026 CID_1355 | CID_1355 | |
| 0.045 | 0.126 | 0.136 | Acetylcholine nicotinic antagonist | 0.136 0.025 CID_1355 | CID_1355 | |
| 0.064 | 0.145 | 0.207 | Protein kinase C zeta inhibitor | 0.207 0.01 CID_1355 | CID_1355 | |
| 0.013 | 0.095 | 0.322 | 5 Hydroxytryptamine 2C agonist | 0.322 0.003 CID_1355 | CID_1355 | |
| 0.054 | 0.137 | 0.107 | Pim-1 kinase inhibitor | 0.107 0.051 CID_1355 | CID_1355 | |
| 0.029 | 0.114 | 0.048 | CF transmembrane conductance regulator antagonist | 0.048 0.01 CID_1355 | CID_1355 | |
| 0.014 | 0.099 | 0.037 | Purinergic P2X7 antagonist | 0.037 0.024 CID_1355 | CID_1355 | |
| 0.084 | 0.171 | 0.171 | Transcription factor STAT6 inhibitor | 0.171 0.013 CID_1355 | CID_1355 | |
| 0.086 | 0.174 | 0.135 | Diuretic | 0.135 0.09 CID_1355 | CID_1355 | |
| 0.023 | 0.113 | 0.205 | 5 Hydroxytryptamine 2B agonist | 0.205 0.002 CID_1355 | CID_1355 | |
| 0.036 | 0.125 | 0.126 | 5 Hydroxytryptamine 5 antagonist | 0.126 0.011 CID_1355 | CID_1355 | |
| 0.021 | 0.111 | 0.036 | Vanilloid 4 antagonist | 0.036 0.016 CID_1355 | CID_1355 | |
| 0.029 | 0.123 | 0.088 | Cyclin-dependent kinase 6 inhibitor | 0.088 0.016 CID_1355 | CID_1355 | |
| 0.025 | 0.127 | 0.049 | Transforming growth factor beta 1 antagonist | 0.049 0.035 CID_1355 | CID_1355 | |
| 0.116 | 0.218 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.149 0.045 CID_1355 | CID_1355 | |
| 0.018 | 0.122 | 0.054 | Estrogen-related receptor beta antagonist | 0.054 0.005 CID_1355 | CID_1355 | |
| 0.042 | 0.148 | 0.192 | ALK inhibitor | 0.192 0.012 CID_1355 | CID_1355 | |
| 0.03 | 0.138 | 0.087 | CC chemokine receptor 2B antagonist | 0.087 0.007 CID_1355 | CID_1355 | |
| 0.035 | 0.144 | 0.089 | Protein kinase C alpha inhibitor | 0.089 0.028 CID_1355 | CID_1355 | |
| 0.073 | 0.182 | 0.23 | Activin receptor-like kinase 2 inhibitor | 0.23 0.026 CID_1355 | CID_1355 | |
| 0.06 | 0.17 | 0.138 | Nav1.3 sodium channel blocker | 0.138 0.056 CID_1355 | CID_1355 | |
| 0.056 | 0.166 | 0.136 | Cystathionine beta-synthase inhibitor | 0.109 0.067 CID_46781917 0.136 0.047 CID_1355 | CID_1355 | |
| 0.043 | 0.153 | 0.17 | Histamine N-methyltransferase inhibitor | 0.17 0.009 CID_1355 | CID_1355 | |
| 0.02 | 0.13 | 0.047 | Protein kinase (CK1) epsilon inhibitor | 0.047 0.016 CID_1355 | CID_1355 | |
| 0.006 | 0.119 | 0.052 | Histamine H4 receptor agonist | 0.052 0.004 CID_1355 | CID_1355 | |
| 0.059 | 0.172 | 0.081 | Ca(v)3.1 blocker | 0.081 0.057 CID_1355 | CID_1355 | |
| 0.186 | 0.299 | 0.323 | MAP kinase kinase 6 inhibitor | 0.323 0.114 CID_1355 | CID_1355 | |
| 0.078 | 0.192 | 0.195 | Acetylcholine M1 receptor antagonist | 0.195 0.045 CID_1355 | CID_1355 | |
| 0.007 | 0.124 | 0.038 | Acetylcholine M4 receptor agonist | 0.038 0.016 CID_1355 | CID_1355 | |
| 0.024 | 0.142 | 0.065 | Potassium channel small-conductance Ca-activated blocker | 0.065 0.015 CID_1355 | CID_1355 | |
| 0.013 | 0.131 | 0.03 | MAP3K8 inhibitor | 0.03 0.017 CID_1355 | CID_1355 | |
| 0.02 | 0.139 | 0.058 | Purinergic P2X antagonist | 0.058 0.025 CID_1355 | CID_1355 | |
| 0.02 | 0.143 | 0.04 | Nicotinic acid receptor 1 agonist | 0.04 0.028 CID_1355 | CID_1355 | |
| 0.027 | 0.153 | 0.105 | Toll-Like receptor 7 antagonist | 0.105 0.018 CID_1355 | CID_1355 | |
| 0.059 | 0.185 | 0.227 | Ribosomal protein S6 kinase inhibitor | 0.227 0.027 CID_1355 | CID_1355 | |
| 0.03 | 0.157 | 0.093 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.093 0.04 CID_1355 | CID_1355 | |
| 0.042 | 0.17 | 0.091 | Exportin-1 inhibitor | 0.091 0.014 CID_1355 | CID_1355 | |
| 0.021 | 0.15 | 0.061 | Histamine H1 receptor agonist | 0.061 0.008 CID_1355 | CID_1355 | |
| 0.019 | 0.147 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 CID_1355 | CID_1355 | |
| 0.034 | 0.165 | 0.063 | Ca(v)3.2 blocker | 0.063 0.033 CID_1355 | CID_1355 | |
| 0.011 | 0.142 | 0.057 | Acetylcholine M1 receptor agonist | 0.057 0.023 CID_1355 | CID_1355 | |
| 0.009 | 0.142 | 0.07 | Methionyl aminopeptidase 1 inhibitor | 0.07 0.004 CID_1355 | CID_1355 | |
| 0.097 | 0.231 | 0.286 | 3C-like protease (Human coronavirus) inhibitor | 0.286 0.015 CID_1355 | CID_1355 | |
| 0.054 | 0.189 | 0.114 | Acetylcholine muscarinic antagonist | 0.114 0.074 CID_1355 | CID_1355 | |
| 0.012 | 0.148 | 0.04 | Acid ceramidase inhibitor | 0.04 0.004 CID_1355 | CID_1355 | |
| 0.05 | 0.187 | 0.117 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.087 CID_1355 | CID_1355 | |
| 0.011 | 0.149 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.025 CID_1355 | CID_1355 | |
| 0.046 | 0.185 | 0.116 | Creatine kinase inhibitor | 0.116 0.044 CID_1355 | CID_1355 | |
| 0.041 | 0.183 | 0.113 | Chemokine receptor antagonist | 0.113 0.053 CID_1355 | CID_1355 | |
| 0.022 | 0.165 | 0.049 | Cholesterol esterase inhibitor | 0.049 0.032 CID_1355 | CID_1355 | |
| 0.055 | 0.198 | 0.114 | Nav1.6 sodium channel blocker | 0.114 0.105 CID_1355 | CID_1355 | |
| 0.006 | 0.15 | 0.02 | Cyclin D2 inhibitor | 0.02 0.004 CID_1355 | CID_1355 | |
| 0.03 | 0.177 | 0.191 | Cyclin B3 inhibitor | 0.191 0.007 CID_1355 | CID_1355 | |
| 0.08 | 0.229 | 0.171 | Heat shock protein 90 alpha antagonist | 0.168 0.071 CID_46781917 0.171 0.069 CID_1355 | CID_1355 | |
| 0.005 | 0.155 | 0.092 | Nicotinic alpha4 receptor agonist | 0.092 0.003 CID_1355 | CID_1355 | |
| 0.039 | 0.192 | 0.098 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.073 CID_1355 | CID_1355 | |
| 0.065 | 0.219 | 0.234 | Toll-Like receptor antagonist | 0.234 0.02 CID_1355 | CID_1355 | |
| 0.008 | 0.162 | 0.065 | Kainate receptor 2 antagonist | 0.065 0.01 CID_1355 | CID_1355 | |
| 0.011 | 0.168 | 0.05 | AMPA receptor antagonist | 0.05 0.031 CID_1355 | CID_1355 | |
| 0.018 | 0.177 | 0.078 | CDK4/cyclin D1 inhibitor | 0.078 0.025 CID_1355 | CID_1355 | |
| 0.013 | 0.173 | 0.07 | Acetylcholine muscarinic agonist | 0.07 0.027 CID_1355 | CID_1355 | |
| 0.024 | 0.184 | 0.13 | Histamine H4 receptor antagonist | 0.13 0.004 CID_1355 | CID_1355 | |
| 0.009 | 0.17 | 0.044 | LFA antagonist | 0.044 0.007 CID_1355 | CID_1355 | |
| 0.05 | 0.213 | 0.148 | Protein kinase C gamma inhibitor | 0.148 0.033 CID_1355 | CID_1355 | |
| 0.004 | 0.169 | 0.031 | AMPA 1 receptor antagonist | 0.031 0.019 CID_1355 | CID_1355 | |
| 0.019 | 0.185 | 0.053 | Benzodiazepine antagonist | 0.053 0.021 CID_1355 | CID_1355 | |
| 0.025 | 0.194 | 0.175 | Nicotinic alpha4beta2 receptor antagonist | 0.175 0.005 CID_1355 | CID_1355 | |
| 0.019 | 0.189 | 0.09 | Nicotinic receptor alpha4 subunit antagonist | 0.09 0.01 CID_1355 | CID_1355 | |
| 0.016 | 0.19 | 0.109 | Toll-Like receptor 8 antagonist | 0.109 0.007 CID_1355 | CID_1355 | |
| 0.024 | 0.198 | 0.073 | 5 Hydroxytryptamine 1B agonist | 0.073 0.016 CID_1355 | CID_1355 | |
| 0.021 | 0.196 | 0.069 | GABA B receptor antagonist | 0.069 0.009 CID_1355 | CID_1355 | |
| 0.019 | 0.194 | 0.065 | Pim-2 kinase inhibitor | 0.065 0.027 CID_1355 | CID_1355 | |
| 0.02 | 0.197 | 0.103 | Histamine agonist | 0.103 0.009 CID_1355 | CID_1355 | |
| 0.02 | 0.198 | 0.065 | Purinergic P2 antagonist | 0.065 0.043 CID_1355 | CID_1355 | |
| 0.003 | 0.182 | 0.019 | Integrin beta2 antagonist | 0.019 0.005 CID_1355 | CID_1355 | |
| 0.021 | 0.203 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.035 CID_1355 | CID_1355 | |
| 0.077 | 0.259 | 0.223 | GABA C receptor rho-2 antagonist | 0.223 0.019 CID_1355 | CID_1355 | |
| 0.017 | 0.2 | 0.057 | Somatostatin 4 agonist | 0.057 0.013 CID_1355 | CID_1355 | |
| 0.016 | 0.2 | 0.064 | CDK4/cyclin D inhibitor | 0.064 0.033 CID_1355 | CID_1355 | |
| 0.006 | 0.191 | 0.018 | CC chemokine 9 receptor antagonist | 0.018 0.01 CID_1355 | CID_1355 | |
| 0.017 | 0.202 | 0.036 | Protein kinase (CK2) beta inhibitor | 0.036 0.017 CID_1355 | CID_1355 | |
| 0.01 | 0.195 | 0.048 | 5 Hydroxytryptamine 6 agonist | 0.048 0.005 CID_1355 | CID_1355 | |
| 0.098 | 0.285 | 0.189 | DNA damaging | 0.189 0.125 CID_1355 | CID_1355 | |
| 0.03 | 0.217 | 0.101 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.101 0.01 CID_1355 | CID_1355 | |
| 0.01 | 0.2 | 0.063 | Cyclin D3 inhibitor | 0.063 0.016 CID_1355 | CID_1355 | |
| 0.119 | 0.31 | 0.256 | ErbB-1 antagonist | 0.256 0.049 CID_1355 | CID_1355 | |
| 0.001 | 0.194 | 0.014 | Melatonin 5 antagonist | 0.014 0.006 CID_1355 | CID_1355 | |
| 0.004 | 0.202 | 0.025 | 5 Hydroxytryptamine 1D agonist | 0.025 0.023 CID_1355 | CID_1355 | |
| 0.021 | 0.219 | 0.059 | CXC chemokine 4 receptor antagonist | 0.059 0.043 CID_1355 | CID_1355 | |
| 0.012 | 0.213 | 0.044 | Estrogen-related receptor gamma antagonist | 0.044 0.004 CID_1355 | CID_1355 | |
| 0.081 | 0.283 | 0.183 | Pregnane X receptor agonist | 0.183 0.017 CID_1355 | CID_1355 | |
| 0.107 | 0.309 | 0.259 | DNA synthesis inhibitor | 0.259 0.061 CID_1355 | CID_1355 | |
| 0.006 | 0.209 | 0.055 | Nicotinic alpha3beta4 receptor agonist | 0.055 0.004 CID_1355 | CID_1355 | |
| 0.022 | 0.228 | 0.069 | CC chemokine receptor antagonist | 0.069 0.064 CID_1355 | CID_1355 | |
| 0.003 | 0.208 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 CID_1355 | CID_1355 | |
| 0.004 | 0.212 | 0.019 | Complement factor D inhibitor | 0.019 0.011 CID_1355 | CID_1355 | |
| 0.015 | 0.225 | 0.065 | CC chemokine 2 receptor antagonist | 0.065 0.028 CID_1355 | CID_1355 | |
| 0.013 | 0.224 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 CID_1355 | CID_1355 | |
| 0.015 | 0.231 | 0.071 | Phosphodiesterase VII inhibitor | 0.071 0.034 CID_1355 | CID_1355 | |
| 0.013 | 0.23 | 0.027 | Complement factor 1r inhibitor | 0.027 0.015 CID_1355 | CID_1355 | |
| 0.101 | 0.319 | 0.713 | 5 Hydroxytryptamine release stimulant | 0.713 0.006 CID_1355 | CID_1355 | |
| 0.014 | 0.234 | 0.109 | Acetylcholine M5 receptor agonist | 0.109 0.015 CID_1355 | CID_1355 | |
| 0.035 | 0.259 | 0.2 | Glutamate receptor antagonist | 0.2 0.025 CID_1355 | CID_1355 | |
| 0.076 | 0.302 | 0.146 | MAP kinase 3 inhibitor | 0.146 0.074 CID_1355 | CID_1355 | |
| 0.005 | 0.231 | 0.055 | Kainate receptor antagonist | 0.055 0.019 CID_1355 | CID_1355 | |
| 0.014 | 0.242 | 0.042 | Poly(ADP-ribose) polymerase inhibitor | 0.042 0.036 CID_1355 | CID_1355 | |
| 0.04 | 0.268 | 0.153 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.153 0.026 CID_1355 | CID_1355 | |
| 0.035 | 0.266 | 0.077 | Neuropeptide Y antagonist | 0.077 0.063 CID_1355 | CID_1355 | |
| 0.005 | 0.236 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 CID_1355 | CID_1355 | |
| 0.005 | 0.237 | 0.026 | Urotensin II antagonist | 0.026 0.012 CID_1355 | CID_1355 | |
| 0.018 | 0.254 | 0.051 | Myc inhibitor | 0.051 0.043 CID_1355 | CID_1355 | |
| 0.091 | 0.327 | 0.239 | Calpain 2 inhibitor | 0.239 0.157 CID_1355 | CID_1355 | |
| 0.024 | 0.261 | 0.085 | Nicotinic alpha3beta2 receptor antagonist | 0.085 0.011 CID_1355 | CID_1355 | |
| 0.083 | 0.32 | 0.153 | Death-associated protein kinase 1 inhibitor | 0.153 0.035 CID_1355 | CID_1355 | |
| 0.013 | 0.251 | 0.04 | AMPA 4 receptor antagonist | 0.04 0.026 CID_1355 | CID_1355 | |
| 0.086 | 0.326 | 0.18 | Thyroid hormone beta antagonist | 0.18 0.174 CID_1355 | CID_1355 | |
| 0.06 | 0.301 | 0.183 | Cyclin-dependent kinase 8 inhibitor | 0.183 0.049 CID_1355 | CID_1355 | |
| 0.027 | 0.269 | 0.065 | Alpha 1b adrenoreceptor agonist | 0.065 0.015 CID_1355 | CID_1355 | |
| 0.12 | 0.363 | 0.279 | Tyrosine 3 hydroxylase inhibitor | 0.279 0.045 CID_1355 | CID_1355 | |
| 0.014 | 0.257 | 0.061 | Nicotinic receptor alpha3 subunit antagonist | 0.061 0.019 CID_1355 | CID_1355 | |
| 0.005 | 0.252 | 0.035 | Cyclin E2 inhibitor | 0.035 0.015 CID_1355 | CID_1355 | |
| 0.064 | 0.312 | 0.179 | DNA methylase inhibitor | 0.179 0.094 CID_1355 | CID_1355 | |
| 0.02 | 0.27 | 0.209 | NMDA receptor antagonist | 0.209 0.013 CID_1355 | CID_1355 | |
| 0.042 | 0.291 | 0.098 | Calcium channel (voltage-sensitive) blocker | 0.098 0.086 CID_1355 | CID_1355 | |
| 0.011 | 0.261 | 0.124 | NMDA receptor subunit 3B antagonist | 0.124 0.008 CID_1355 | CID_1355 | |
| 0.018 | 0.268 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.027 CID_1355 | CID_1355 | |
| 0.048 | 0.302 | 0.342 | NADPH oxidase inhibitor | 0.342 0.008 CID_1355 | CID_1355 | |
| 0.02 | 0.276 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.042 CID_1355 | CID_1355 | |
| 0.015 | 0.271 | 0.049 | Adenylate cyclase 1 inhibitor | 0.049 0.027 CID_1355 | CID_1355 | |
| 0.021 | 0.28 | 0.09 | Alpha 1L adrenoreceptor agonist | 0.09 0.003 CID_1355 | CID_1355 | |
| 0.019 | 0.277 | 0.053 | Dopamine beta hydroxylase inhibitor | 0.053 0.025 CID_1355 | CID_1355 | |
| 0.037 | 0.296 | 0.111 | GABA B receptor agonist | 0.111 0.01 CID_1355 | CID_1355 | |
| 0.008 | 0.268 | 0.02 | Factor XIII inhibitor | 0.02 0.017 CID_1355 | CID_1355 | |
| 0.053 | 0.314 | 0.139 | Heat shock protein 90 antagonist | 0.136 0.09 CID_46781917 0.139 0.087 CID_1355 | CID_1355 | |
| 0.031 | 0.295 | 0.089 | Sphingomyelinase inhibitor | 0.089 0.074 CID_1355 | CID_1355 | |
| 0.01 | 0.275 | 0.036 | Melanocortin 1 antagonist | 0.036 0.029 CID_1355 | CID_1355 | |
| 0.009 | 0.278 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 CID_1355 | CID_1355 | |
| 0.039 | 0.31 | 0.171 | Electrolyte absorption antagonist | 0.171 0.013 CID_1355 | CID_1355 | |
| 0.013 | 0.288 | 0.06 | EphB4 antagonist | 0.06 0.038 CID_1355 | CID_1355 | |
| 0.038 | 0.315 | 0.141 | NADH dehydrogenase inhibitor | 0.141 0.02 CID_1355 | CID_1355 | |
| 0.013 | 0.29 | 0.077 | Cyclin A1 inhibitor | 0.077 0.016 CID_1355 | CID_1355 | |
| 0.023 | 0.3 | 0.06 | Pregnane X receptor antagonist | 0.06 0.032 CID_1355 | CID_1355 | |
| 0.038 | 0.317 | 0.071 | Calcium channel P-type blocker | 0.071 0.027 CID_1355 | CID_1355 | |
| 0.056 | 0.337 | 0.143 | DNA methyltransferase I inhibitor | 0.143 0.111 CID_1355 | CID_1355 | |
| 0.006 | 0.287 | 0.032 | Myristoyl transferase inhibitor | 0.032 0.011 CID_1355 | CID_1355 | |
| 0.012 | 0.303 | 0.066 | Dopamine transporter inhibitor | 0.066 0.022 CID_1355 | CID_1355 | |
| 0.026 | 0.319 | 0.09 | Myeloperoxidase inhibitor | 0.09 0.049 CID_1355 | CID_1355 | |
| 0.07 | 0.365 | 0.222 | Focal adhesion kinase 2 inhibitor | 0.222 0.053 CID_1355 | CID_1355 | |
| 0.022 | 0.322 | 0.053 | Sodium/calcium exchanger inhibitor | 0.053 0.029 CID_1355 | CID_1355 | |
| 0.005 | 0.311 | 0.082 | NMDA receptor subunit 3A antagonist | 0.082 0.011 CID_1355 | CID_1355 | |
| 0.004 | 0.311 | 0.053 | Nicotinic alpha4beta2 receptor agonist | 0.053 0.004 CID_1355 | CID_1355 | |
| 0.008 | 0.316 | 0.032 | CDK4/cyclin D3 inhibitor | 0.032 0.016 CID_1355 | CID_1355 | |
| 0.026 | 0.335 | 0.086 | ATPase (Vacuolar H+) inhibitor | 0.086 0.064 CID_131770015 0.082 0.074 CID_1355 | CID_131770015 | |
| 0.028 | 0.339 | 0.072 | Viral attachment inhibitor | 0.072 0.069 CID_1355 | CID_1355 | |
| 0.017 | 0.327 | 0.065 | CDK1/cyclin B1 inhibitor | 0.065 0.054 CID_1355 | CID_1355 | |
| 0.022 | 0.336 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 CID_1355 | CID_1355 | |
| 0.008 | 0.322 | 0.112 | NMDA 2C receptor antagonist | 0.112 0.012 CID_1355 | CID_1355 | |
| 0.019 | 0.338 | 0.068 | Cyclin H inhibitor | 0.068 0.03 CID_1355 | CID_1355 | |
| 0.013 | 0.334 | 0.06 | Beta 1 adrenoreceptor antagonist | 0.06 0.036 CID_1355 | CID_1355 | |
| 0.04 | 0.361 | 0.083 | MAP kinase 7 inhibitor | 0.083 0.035 CID_1355 | CID_1355 | |
| 0.006 | 0.327 | 0.024 | Geranylgeranyltransferase inhibitor | 0.024 0.013 CID_1355 | CID_1355 | |
| 0.033 | 0.36 | 0.102 | Vanilloid 4 agonist | 0.102 0.015 CID_1355 | CID_1355 | |
| 0.09 | 0.418 | 0.268 | Vasodilator, coronary | 0.268 0.117 CID_1355 | CID_1355 | |
| 0.03 | 0.364 | 0.17 | GABA C receptor rho-1 antagonist | 0.17 0.014 CID_1355 | CID_1355 | |
| 0.037 | 0.373 | 0.111 | Calcium channel blocker | 0.111 0.098 CID_1355 | CID_1355 | |
| 0.007 | 0.346 | 0.063 | Alpha 1d adrenoreceptor agonist | 0.063 0.01 CID_1355 | CID_1355 | |
| 0.045 | 0.385 | 0.097 | T cell inhibitor | 0.097 0.028 CID_1355 | CID_1355 | |
| 0.056 | 0.397 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.064 CID_1355 | CID_1355 | |
| 0.015 | 0.358 | 0.154 | Purinergic P2X4 antagonist | 0.154 0.004 CID_1355 | CID_1355 | |
| 0.047 | 0.39 | 0.113 | Glutamate release inhibitor | 0.113 0.027 CID_1355 | CID_1355 | |
| 0.021 | 0.366 | 0.103 | Protein kinase C delta inhibitor | 0.103 0.05 CID_1355 | CID_1355 | |
| 0.01 | 0.357 | 0.077 | Cyclin B1 inhibitor | 0.077 0.025 CID_1355 | CID_1355 | |
| 0.05 | 0.398 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | 0.135 0.065 CID_1355 | CID_1355 | |
| 0.077 | 0.429 | 0.191 | Neurotensin receptor agonist | 0.191 0.04 CID_1355 | CID_1355 | |
| 0.028 | 0.383 | 0.149 | Beta glucuronidase inhibitor | 0.149 0.025 CID_1355 | CID_1355 | |
| 0.005 | 0.362 | 0.03 | Calcium-sensing receptor agonist | 0.03 0.013 CID_1355 | CID_1355 | |
| 0.005 | 0.363 | 0.17 | NMDA 2 receptor antagonist | 0.17 0.013 CID_1355 | CID_1355 | |
| 0.072 | 0.432 | 0.268 | Neuropeptide Y2 antagonist | 0.268 0.04 CID_1355 | CID_1355 | |
| 0.02 | 0.381 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 CID_1355 | CID_1355 | |
| 0.003 | 0.364 | 0.029 | NMDA receptor glycine site antagonist | 0.029 0.013 CID_1355 | CID_1355 | |
| 0.059 | 0.421 | 0.165 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.165 0.125 CID_1355 | CID_1355 | |
| 0.008 | 0.372 | 0.083 | Nicotinic receptor alpha7 subunit antagonist | 0.083 0.016 CID_1355 | CID_1355 | |
| 0.059 | 0.425 | 0.189 | Neurotrophic factor enhancer | 0.189 0.088 CID_1355 | CID_1355 | |
| 0.005 | 0.37 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 CID_1355 | CID_1355 | |
| 0.022 | 0.393 | 0.164 | Protein kinase C mu inhibitor | 0.164 0.02 CID_1355 | CID_1355 | |
| 0.006 | 0.378 | 0.084 | NMDA 2A receptor antagonist | 0.084 0.018 CID_1355 | CID_1355 | |
| 0.008 | 0.381 | 0.103 | NMDA receptor glycine site agonist | 0.103 0.015 CID_1355 | CID_1355 | |
| 0.008 | 0.384 | 0.065 | Cyclin B inhibitor | 0.065 0.026 CID_1355 | CID_1355 | |
| 0.024 | 0.4 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 CID_1355 | CID_1355 | |
| 0.004 | 0.385 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.024 CID_1355 | CID_1355 | |
| 0.077 | 0.458 | 0.21 | RNA-directed DNA polymerase inhibitor | 0.21 0.086 CID_1355 | CID_1355 | |
| 0.019 | 0.401 | 0.092 | Falcipain 3 inhibitor | 0.092 0.079 CID_1355 | CID_1355 | |
| 0.125 | 0.511 | 0.226 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.226 0.103 CID_1355 | CID_1355 | |
| 0.047 | 0.435 | 0.197 | Succinate dehydrogenase inhibitor | 0.197 0.051 CID_1355 | CID_1355 | |
| 0.018 | 0.41 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.023 CID_1355 | CID_1355 | |
| 0.006 | 0.399 | 0.057 | Dopamine D5 agonist | 0.057 0.013 CID_1355 | CID_1355 | |
| 0.002 | 0.397 | 0.022 | Cyclin T1 inhibitor | 0.022 0.009 CID_1355 | CID_1355 | |
| 0.011 | 0.406 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.01 CID_1355 | CID_1355 | |
| 0.022 | 0.417 | 0.169 | Ferrochelatase inhibitor | 0.169 0.031 CID_1355 | CID_1355 | |
| 0.004 | 0.401 | 0.033 | Carnitine palmitoyltransferase inhibitor | 0.033 0.026 CID_1355 | CID_1355 | |
| 0.004 | 0.402 | 0.055 | Glycine transporter inhibitor | 0.055 0.028 CID_1355 | CID_1355 | |
| 0.028 | 0.428 | 0.09 | Bile acid receptor antagonist | 0.09 0.073 CID_1355 | CID_1355 | |
| 0.05 | 0.453 | 0.179 | Tumour necrosis factor antagonist | 0.179 0.068 CID_1355 | CID_1355 | |
| 0.018 | 0.422 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.103 0.06 CID_1355 | CID_1355 | |
| 0.005 | 0.409 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.023 CID_1355 | CID_1355 | |
| 0.032 | 0.439 | 0.142 | Mannose-6-phosphate isomerase inhibitor | 0.142 0.072 CID_1355 | CID_1355 | |
| 0.014 | 0.424 | 0.085 | NMDA receptor agonist | 0.085 0.026 CID_1355 | CID_1355 | |
| 0.089 | 0.501 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.052 CID_1355 | CID_1355 | |
| 0.042 | 0.456 | 0.196 | Hexokinase inhibitor | 0.196 0.037 CID_1355 | CID_1355 | |
| 0.042 | 0.455 | 0.329 | Interleukin agonist | 0.329 0.036 CID_1355 | CID_1355 | |
| 0.022 | 0.437 | 0.093 | MAP kinase kinase 1 inhibitor | 0.093 0.066 CID_1355 | CID_1355 | |
| 0.007 | 0.425 | 0.065 | Cyclin B2 inhibitor | 0.065 0.027 CID_1355 | CID_1355 | |
| 0.043 | 0.461 | 0.153 | Antipruritic | 0.153 0.091 CID_1355 | CID_1355 | |
| 0.103 | 0.522 | 0.419 | 5 Hydroxytryptamine uptake stimulant | 0.419 0.011 CID_1355 | CID_1355 | |
| 0.063 | 0.485 | 0.226 | Gastrin inhibitor | 0.226 0.11 CID_1355 | CID_1355 | |
| 0.012 | 0.439 | 0.05 | Acid-sensing ion channel blocker | 0.05 0.016 CID_1355 | CID_1355 | |
| 0.064 | 0.494 | 0.161 | Death-associated protein kinase 2 inhibitor | 0.161 0.083 CID_1355 | CID_1355 | |
| 0.003 | 0.435 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 CID_1355 | CID_1355 | |
| 0.044 | 0.477 | 0.154 | Adenylate cyclase stimulant | 0.154 0.056 CID_1355 | CID_1355 | |
| 0.022 | 0.455 | 0.152 | AMP-activated protein kinase stimulant | 0.152 0.027 CID_1355 | CID_1355 | |
| 0.019 | 0.452 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.054 CID_1355 | CID_1355 | |
| 0.008 | 0.444 | 0.059 | Cyclin A2 inhibitor | 0.059 0.048 CID_1355 | CID_1355 | |
| 0.013 | 0.451 | 0.112 | Calcium antagonist | 0.112 0.039 CID_1355 | CID_1355 | |
| 0.008 | 0.447 | 0.036 | Integrin alpha2 antagonist | 0.036 0.026 CID_1355 | CID_1355 | |
| 0.002 | 0.441 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.037 0.004 CID_1355 | CID_1355 | |
| 0.015 | 0.456 | 0.117 | Polo-like kinase-4 inhibitor | 0.117 0.059 CID_1355 | CID_1355 | |
| 0.005 | 0.448 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 CID_1355 | CID_1355 | |
| 0.018 | 0.462 | 0.183 | GABA C receptor antagonist | 0.183 0.017 CID_1355 | CID_1355 | |
| 0.015 | 0.459 | 0.115 | Urease inhibitor | 0.115 0.05 CID_1355 | CID_1355 | |
| 0.054 | 0.499 | 0.194 | Antithrombotic | 0.194 0.185 CID_1355 | CID_1355 | |
| 0.007 | 0.454 | 0.055 | Cyclin A inhibitor | 0.055 0.048 CID_1355 | CID_1355 | |
| 0.01 | 0.458 | 0.064 | Sphingosine kinase 2 inhibitor | 0.064 0.027 CID_1355 | CID_1355 | |
| 0.015 | 0.467 | 0.09 | EphA2 antagonist | 0.09 0.087 CID_1355 | CID_1355 | |
| 0.054 | 0.506 | 0.138 | Sphingosine 1-phosphate receptor 5 antagonist | 0.138 0.083 CID_1355 | CID_1355 | |
| 0.014 | 0.469 | 0.164 | Glycine receptor antagonist | 0.164 0.005 CID_1355 | CID_1355 | |
| 0.015 | 0.471 | 0.069 | Cathepsin G inhibitor | 0.069 0.055 CID_1355 | CID_1355 | |
| 0.003 | 0.461 | 0.043 | Diamine oxidase inhibitor | 0.043 0.02 CID_1355 | CID_1355 | |
| 0.062 | 0.523 | 0.334 | Vasodilator, peripheral | 0.334 0.081 CID_1355 | CID_1355 | |
| 0.012 | 0.473 | 0.069 | Aryl hydrocarbon receptor antagonist | 0.069 0.039 CID_1355 | CID_1355 | |
| 0.054 | 0.515 | 0.275 | Cholesterol antagonist | 0.275 0.108 CID_1355 | CID_1355 | |
| 0.026 | 0.488 | 0.171 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.171 0.12 CID_1355 | CID_1355 | |
| 0.008 | 0.47 | 0.141 | Alpha 2 adrenoreceptor agonist | 0.141 0.007 CID_1355 | CID_1355 | |
| 0.02 | 0.483 | 0.121 | Cyclin-dependent kinase 7 inhibitor | 0.121 0.084 CID_1355 | CID_1355 | |
| 0.006 | 0.47 | 0.075 | Nav1.7 sodium channel blocker | 0.075 0.038 CID_1355 | CID_1355 | |
| 0.032 | 0.502 | 0.174 | Peroxidase inhibitor | 0.174 0.067 CID_1355 | CID_1355 | |
| 0.003 | 0.48 | 0.054 | Imidazoline I1 receptor antagonist | 0.054 0.004 CID_1355 | CID_1355 | |
| 0.026 | 0.506 | 0.1 | Alpha 2d adrenoreceptor antagonist | 0.1 0.049 CID_1355 | CID_1355 | |
| 0.041 | 0.52 | 0.197 | ATPase inhibitor | 0.197 0.04 CID_1355 | CID_1355 | |
| 0.017 | 0.498 | 0.221 | Aryl hydrocarbon receptor agonist | 0.221 0.092 CID_1355 | CID_1355 | |
| 0.065 | 0.546 | 0.175 | Catenin beta inhibitor | 0.175 0.059 CID_1355 | CID_1355 | |
| 0.017 | 0.499 | 0.199 | GABA C receptor agonist | 0.199 0.02 CID_1355 | CID_1355 | |
| 0.022 | 0.509 | 0.128 | HIV-1 integrase (Overall Integration) inhibitor | 0.128 0.035 CID_1355 | CID_1355 | |
| 0.017 | 0.505 | 0.134 | MAP-kinase-activated kinase inhibitor | 0.134 0.02 CID_1355 | CID_1355 | |
| 0.045 | 0.535 | 0.273 | Hypoxia-inducible factor 1 alpha inhibitor | 0.273 0.081 CID_1355 | CID_1355 | |
| 0.023 | 0.517 | 0.12 | Toll-Like receptor 2 antagonist | 0.12 0.077 CID_1355 | CID_1355 | |
| 0.042 | 0.537 | 0.162 | CF transmembrane conductance regulator agonist | 0.162 0.057 CID_1355 | CID_1355 | |
| 0.012 | 0.511 | 0.12 | MAP-kinase-activated kinase 2 inhibitor | 0.12 0.02 CID_1355 | CID_1355 | |
| 0.017 | 0.526 | 0.233 | MAP kinase kinase 2 inhibitor | 0.233 0.062 CID_1355 | CID_1355 | |
| 0.022 | 0.536 | 0.147 | Interleukin 8 antagonist | 0.147 0.036 CID_1355 | CID_1355 | |
| 0.015 | 0.533 | 0.124 | Potassium channel (Ca-activated) activator | 0.124 0.039 CID_1355 | CID_1355 | |
| 0.011 | 0.53 | 0.15 | LIM domain kinase 1 inhibitor | 0.15 0.098 CID_1355 | CID_1355 | |
| 0.01 | 0.529 | 0.083 | Potassium channel (Voltage-sensitive) activator | 0.083 0.082 CID_1355 | CID_1355 | |
| 0.018 | 0.538 | 0.08 | Glycine receptor agonist | 0.08 0.039 CID_1355 | CID_1355 | |
| 0.011 | 0.531 | 0.059 | I kappa B kinase 2 inhibitor | 0.059 0.048 CID_1355 | CID_1355 | |
| 0.022 | 0.542 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.04 CID_1355 | CID_1355 | |
| 0.02 | 0.54 | 0.109 | Cathepsin H inhibitor | 0.109 0.09 CID_1355 | CID_1355 | |
| 0.024 | 0.545 | 0.115 | Amylase inhibitor | 0.115 0.084 CID_1355 | CID_1355 | |
| 0.031 | 0.554 | 0.139 | Aurora-C kinase inhibitor | 0.139 0.066 CID_1355 | CID_1355 | |
| 0.036 | 0.561 | 0.228 | 15-Lipoxygenase inhibitor | 0.228 0.184 CID_1355 | CID_1355 | |
| 0.029 | 0.554 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.092 0.041 CID_1355 | CID_1355 | |
| 0.03 | 0.558 | 0.101 | CDK3/cyclin E inhibitor | 0.101 0.086 CID_1355 | CID_1355 | |
| 0.005 | 0.536 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.028 CID_1355 | CID_1355 | |
| 0.018 | 0.551 | 0.181 | I kappa B kinase epsilon inhibitor | 0.181 0.088 CID_1355 | CID_1355 | |
| 0.024 | 0.561 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.088 CID_1355 | CID_1355 | |
| 0.003 | 0.548 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 CID_1355 | CID_1355 | |
| 0.028 | 0.577 | 0.096 | Glutamate (mGluR7) agonist | 0.096 0.069 CID_1355 | CID_1355 | |
| 0.008 | 0.559 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.014 CID_1355 | CID_1355 | |
| 0.027 | 0.577 | 0.129 | Thiol protease inhibitor | 0.129 0.099 CID_1355 | CID_1355 | |
| 0.026 | 0.577 | 0.192 | 12-Lipoxygenase inhibitor | 0.192 0.161 CID_1355 | CID_1355 | |
| 0.014 | 0.566 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.045 CID_1355 | CID_1355 | |
| 0.019 | 0.57 | 0.132 | Arachidonic acid antagonist | 0.132 0.11 CID_1355 | CID_1355 | |
| 0.008 | 0.563 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.014 CID_1355 | CID_1355 | |
| 0.011 | 0.57 | 0.087 | Potassium channel activator | 0.087 0.064 CID_1355 | CID_1355 | |
| 0.032 | 0.601 | 0.231 | Phospholipase C inhibitor | 0.231 0.029 CID_1355 | CID_1355 | |
| 0.001 | 0.573 | 0.011 | Imidazoline I2 receptor antagonist | 0.011 0.008 CID_1355 | CID_1355 | |
| 0.038 | 0.61 | 0.238 | Antibacterial | 0.238 0.189 CID_1355 | CID_1355 | |
| 0.01 | 0.588 | 0.077 | I kappa B kinase inhibitor | 0.077 0.064 CID_1355 | CID_1355 | |
| 0.01 | 0.588 | 0.057 | Botulinum neurotoxin type A inhibitor | 0.057 0.042 CID_1355 | CID_1355 | |
| 0.008 | 0.586 | 0.059 | Epithelial sodium channel blocker | 0.059 0.03 CID_1355 | CID_1355 | |
| 0.024 | 0.607 | 0.155 | Cyclooxygenase 3 inhibitor | 0.155 0.044 CID_1355 | CID_1355 | |
| 0.005 | 0.588 | 0.06 | Androgen agonist | 0.06 0.041 CID_1355 | CID_1355 | |
| 0.005 | 0.589 | 0.02 | Alpha 1a adrenoreceptor agonist | 0.02 0.018 CID_1355 | CID_1355 | |
| 0.069 | 0.657 | 0.222 | Nitric-oxide synthase stimulant | 0.222 0.058 CID_1355 | CID_1355 | |
| 0.031 | 0.656 | 0.181 | Transcription factor STAT inhibitor | 0.181 0.166 CID_1355 | CID_1355 | |
| 0.002 | 0.646 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 CID_1355 | CID_1355 | |
| 0.013 | 0.658 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.148 0.056 CID_1355 | CID_1355 | |
| 0.034 | 0.697 | 0.216 | Insulysin inhibitor | 0.216 0.134 CID_1355 | CID_1355 | |
| 0.016 | 0.682 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.023 CID_1355 | CID_1355 | |
| 0.004 | 0.698 | 0.082 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 CID_1355 | CID_1355 | |
| 0.006 | 0.709 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.083 CID_1355 | CID_1355 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |